In what is perhaps the largest study to date to evaluate the impact of neonatal infection on adverse outcomes in early childhood, researchers have found that neonatal infections among extremely low-birthweight (ELBW) infants are associated with serious adverse neurodevelopmental and growth outcomes in early childhood that contribute to long-term disability.
In what is perhaps the largest study to date to evaluate the impact of neonatal infection on adverse outcomes in early childhood, researchers have found that neonatal infections among extremely low-birthweight (ELBW) infants are associated with serious adverse neurodevelopmental and growth outcomes in early childhood that contribute to long-term disability.
The prospective cohort study included over 6,000 infants weighing 401 to 1,000 g at birth. Sixty-five percent of the ELBW survivors had at least one infection during their postbirth hospital stay: 1,538 developed clinical infection alone; 1,922 developed sepsis alone; 279 developed sepsis and necrotizing enterocolitis (NEC); and 193 developed meningitis with or without sepsis.
Compared with uninfected infants, those who were in any of the four infection groups were significantly more likely to develop cerebral palsy (range of significant odds ratio [OR], 1.4-1.7), low Bayley Scales of Infant Development II scores on the mental development index (OR, 1.3-1.6) and psychomotor development index (OR, 1.5-2.4), and vision impairment (OR, 1.3-2.2). Infants with sepsis and NEC were at highest risk for adverse outcomes.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More